MedTrace Logo

Exercise Intervention for Bone Tumor Patients

NCT04963517 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 11

Last updated 2024-12-06

No results posted yet for this study

Summary

The proGait-study is a two-arm exercise intervention study for AYA-patients with lower extremity tumor endoprosthesis in the follow-up care. This clinical trial will investigate the effects of an 8-week personalized multi-modal exercise intervention of lower extremity muscles on gait quality in adolescents and young adults with cancer diagnosis beginning at least 12 months after endoprosthesis implantation.

Conditions

  • Bone Sarcoma

Interventions

BEHAVIORAL

Exercise therapy

8 weeks personalized, multi-modal exercise with focus on lower extremity

OTHER

Information

* Initial consultation with recommendations for general physical activity * Brochure with exercise recommendations.

Sponsors & Collaborators

  • Ruhr University of Bochum

    collaborator OTHER

  • Universität Duisburg-Essen

    lead OTHER

Principal Investigators

  • Miriam Götte, PhD · University Hospital, Essen

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-07
Primary Completion
2021-12-31
Completion
2022-05-01

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04963517 on ClinicalTrials.gov